These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31705612)

  • 61. A Genetic Variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa Clinical Trials and Regulates Expression of BCL2.
    Liu M; Degner J; Georgantas RW; Nader A; Mostafa NM; Teixeira HD; Williams DA; Kirsner RS; Nichols AJ; Davis JW; Waring JF
    J Invest Dermatol; 2020 Mar; 140(3):574-582.e2. PubMed ID: 31465739
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.
    Fattore D; Pistone G; Bongiorno MR
    G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847
    [No Abstract]   [Full Text] [Related]  

  • 63. Advances in biologic and small molecule therapies for hidradenitis suppurativa.
    Chen SX; Greif C; Gibson RS; Porter ML; Kimball AB
    Expert Opin Pharmacother; 2022 Jun; 23(8):959-978. PubMed ID: 35470765
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hidradenitis suppurativa in association with keratitis-ichthyosis-deafness syndrome treated with adalimumab.
    Song YM; Kim YS; Lee JH; Park YM; Lee JY
    J Dermatol; 2018 Sep; 45(9):e262-e263. PubMed ID: 29570225
    [No Abstract]   [Full Text] [Related]  

  • 65. Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: the 1-year SOLACE study.
    Gulliver W; Alavi A; Wiseman MC; Gooderham MJ; Rao J; Alam MS; Papp KA; Desjardins O; Jean C
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2431-2439. PubMed ID: 34378812
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hidradenitis Suppurativa and the Association With Hematological Malignancies.
    Sotoodian B; Abbas M; Brassard A
    J Cutan Med Surg; 2017; 21(2):158-161. PubMed ID: 27573126
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduction in pain scores and improvement in depressive symptoms in patients with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial.
    Scheinfeld N; Sundaram M; Teixeira H; Gu Y; Okun M
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136622
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interventions for Hidradenitis Suppurativa: Updated Summary of an Original Cochrane Review.
    Ingram JR
    JAMA Dermatol; 2017 May; 153(5):458-459. PubMed ID: 28355440
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?
    Martina E; Campanati A; Giuliodori K; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):21-23. PubMed ID: 28352932
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs.
    Burzi L; Repetto F; Ribero S; Mastorino L; Quaglino P; Dapavo P
    Dermatol Ther; 2022 Dec; 35(12):e15866. PubMed ID: 36175129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adalimumab every other week combined with dexamethasone pulses for the treatment of refractory hidradenitis suppurativa.
    Molina-Leyva A
    Dermatol Ther; 2019 May; 32(3):e12885. PubMed ID: 30945795
    [No Abstract]   [Full Text] [Related]  

  • 72. Management of patients with hidradenitis suppurativa.
    Martorell A; Caballero A; González Lama Y; Jiménez-Gallo D; Lázaro Serrano M; Miranda J; Pascual JC; Salgado-Boquete L; Marín-Jiménez I
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():32-42. PubMed ID: 28081768
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Malignancy and infection risk during adalimumab therapy in hidradenitis suppurativa.
    Frew JW; Jiang CS; Singh N; Grand D; Navrazhina K; Vaughan R; Krueger JG
    Clin Exp Dermatol; 2020 Oct; 45(7):859-865. PubMed ID: 32358868
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biologic Treatment for Hidradenitis Suppurativa.
    Flood KS; Porter ML; Kimball AB
    Am J Clin Dermatol; 2019 Oct; 20(5):625-638. PubMed ID: 31140067
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adalimumab (Humira
    Gupta AK; Cernea M; Abramovits W; Vincent KD
    Skinmed; 2016; 14(4):291-294. PubMed ID: 27784520
    [No Abstract]   [Full Text] [Related]  

  • 76. Disparate results in studies of adalimumab in the treatment of hidradenitis suppurativa: comment on the article by Amano et al.
    Blanco R; González-López MA; González-Vela MC; Fernández-Llaca H; González-Gay MA
    Int J Dermatol; 2013 Mar; 52(3):380-1. PubMed ID: 23414167
    [No Abstract]   [Full Text] [Related]  

  • 77. Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II.
    Kimball AB; Tzellos T; Calimlim BM; Teixeira HD; Geng Z; Okun MM
    Acta Derm Venereol; 2018 Nov; 98(10):932-937. PubMed ID: 30085324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa.
    Porter ML; Golbari NM; Lockwood SJ; Kimball AB
    Semin Cutan Med Surg; 2018 Sep; 37(3):182-189. PubMed ID: 30215636
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fatal New-Onset Congestive Heart Failure Related to Adalimumab Use in a Patient with Relapsing Hidradenitis Suppurativa: A Case Report.
    Mansitó López C; Torres Laboy P; Ortiz Bou M; Quintero Noriega A; Cintron Rivera V
    Am J Case Rep; 2021 Feb; 22():e929148. PubMed ID: 33563886
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.